What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Turk J Gastroenterol. 2010 Mar;21(1):107-12. doi: 10.4318/tjg.2010.0066.
No abstract available

Publication types

  • Review

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Crohn Disease / drug therapy*
  • Humans
  • Infliximab
  • Remission Induction / methods
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab